enGene Holdings Inc
ENGN4.064USD
+0.234+6.10%
Market hours （ET）Quotes delayed by 15 min
207.53MMarket Cap
LossP/E TTM
More Details of enGene Holdings Inc Company
enGene Holdings Inc. is a clinical-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The Company’s lead program is detalimogene voraplasmid, (detalimogene) for patients with non-muscle invasive bladder cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase II study, which includes a cohort studying detalimogene in Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (Cis). Detalimogene is being developed through its proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. The Company is developing non-viral genetic medicines based on its DDX gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Company Info
Ticker SymbolENGN
Company nameenGene Holdings Inc
IPO dateDec 10, 2021
CEOMr. Ronald Harold Wilfred (Ron) Cooper
Number of employees56
Security typeOrdinary Share
Fiscal year-endDec 10
Address4868 Rue Levy, Suite 220
CitySAINT-LAURENT
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeH4R 2P1
Phone15143324888
Websitehttps://engene.com/
Ticker SymbolENGN
IPO dateDec 10, 2021
CEOMr. Ronald Harold Wilfred (Ron) Cooper
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Hastings
Mr. Paul Hastings
Director
Director
--
--
Mr. Gerry Brunk
Mr. Gerry Brunk
Independent Director
Independent Director
--
--
Dr. Anthony T. Cheung, Ph.D.
Dr. Anthony T. Cheung, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Joan Connolly
Ms. Joan Connolly
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Lee G. Giguere
Mr. Lee G. Giguere
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
--
--
Dr. Alexander (Alex) Nichols
Dr. Alexander (Alex) Nichols
Chief Strategy and Operations Officer
Chief Strategy and Operations Officer
--
--
Ms. Lota S. Zoth, CPA
Ms. Lota S. Zoth, CPA
Director
Director
--
--
Mr. Ryan Daws
Mr. Ryan Daws
Chief Financial Officer and Head - Business Development
Chief Financial Officer and Head - Business Development
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Director
Director
--
--
Mr. Ronald Harold Wilfred (Ron) Cooper
Mr. Ronald Harold Wilfred (Ron) Cooper
Chief Executive Officer, President and Director
Chief Executive Officer, President and Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Hastings
Mr. Paul Hastings
Director
Director
--
--
Mr. Gerry Brunk
Mr. Gerry Brunk
Independent Director
Independent Director
--
--
Dr. Anthony T. Cheung, Ph.D.
Dr. Anthony T. Cheung, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Joan Connolly
Ms. Joan Connolly
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Lee G. Giguere
Mr. Lee G. Giguere
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
--
--
Dr. Alexander (Alex) Nichols
Dr. Alexander (Alex) Nichols
Chief Strategy and Operations Officer
Chief Strategy and Operations Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
No Data
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
